ZDGE Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Loading...
ZDGE is not a good buy right now for an impatient trader. Price is sitting on/just under near-term support (around $3.12) with bearish momentum (MACD worsening) and the statistical next-week/next-month bias is negative. Without an Intellectia entry signal or a clear reversal trigger, the odds favor further downside or chop rather than an immediate, reliable bounce.
Trend/Momentum: Bearish-to-weak. MACD histogram is -0.0867 (below zero) and negatively expanding, signaling downside momentum is strengthening. RSI(6) is 27.9, which is effectively oversold/near-oversold, so a bounce is possible, but it is not confirmed.
Moving averages: Converging MAs suggest indecision/transition, not a confirmed uptrend.
Key levels: Current $3.11 is essentially at S1 ($3.119) and below the pivot ($3.398). If support fails, next support is S2 ($2.947). Upside resistance levels are R1 ($3.677) and R2 ($3.849), meaning the stock would need to reclaim the pivot first to shift the short-term bias.
Pattern-based short-horizon probabilities: Similar-pattern read implies ~-5.85% over the next week and ~-4.78% over the next month, reinforcing a cautious/negative near-term setup.
Intellectia Proprietary Trading Signals
after Q1 beat, highlighting ads/subscriptions strength.
Near-term technical momentum is bearish: MACD is below zero and deteriorating; price is below pivot ($3.398).
Downside risk if support breaks: A clean loss of ~$3.12 opens room toward ~$2.95 (S2).
No news/catalyst in the last week to force a reversal.
Short-horizon pattern outlook is negative (expected weakness next week/month in the provided similarity analysis).
Latest quarter: 2026/Q1. Revenue grew to $7.61M (+5.78% YoY), and gross margin improved to ~89.87% (+1.78% YoY), which is constructive on the top line and profitability profile. However, bottom line weakened sharply: Net income fell to $0.788M (-332.45% YoY) and EPS dropped to $0.06 (-400% YoY). The mix of modest revenue growth but sharply lower earnings is a near-term negative for momentum investors/traders.
Recent trend: Limited coverage in the provided data, but the notable update is positive—on 2025-12-15, Maxim raised its price target to $6 (from $5) and maintained a Buy rating after Q1 results topped estimates. Wall Street-style pros: Evidence of revenue growth, very high gross margins, and new product/AI-monetization initiatives that could expand the story. Cons: Earnings/EPS deterioration in the latest quarter and current bearish technical setup; without a confirmed trend reversal, the stock may not respond immediately to the longer-term bull thesis. Influential/political flows: No recent congress trading data; hedge funds and insiders show neutral activity (no significant recent trend).
